Tim Tinnel discusses the effect of tariffs on the pharmaceutical supply chain

With recent U.S. tariffs placing the pharmacutical supply chain under significant pressure, Drug Discovery News spoke with Tim Tinnel, Executive Vice President and Chief Operating Officer of Intelliguard, to discuss how healthcare systems are adapting to rising costs, sourcing uncertainty, and medication shortages by investing in smarter technologies and more agile inventory management approaches.